Physician profile
James S Bembry
NPI 1962468165
$947.51
in general payments reported to CMS, 2019-2025
15 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $325 · 2024: $288 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $853.51 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $297.02 | 2023-2025 | Veozah |
| Abbvie INC. | $126.13 | 2023-2025 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $88.54 | 2023-2024 | |
| Exeltis, USA INC. | $78.28 | 2023-2025 | Slynd |
| Ethicon US, LLC | $62.67 | 2025 | Surgicel Nu-Knit, Dermabond Prineo, Stratafix |
| Coopersurgical, INC. | $53.73 | 2023-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Sumitomo Pharma America, INC. | $44.43 | 2023 | Myfembree |
| Biogen, INC. | $41.39 | 2025 | Zurzuvae |
| Channel Medsystems, INC. | $39.42 | 2023 | |
| Hologic Sales and Service, LLC | $30.05 | 2024 | Aptima, Thinprep 2000 Processor, Novasure |
| Organon LLC | $27.18 | 2024 | |
| Sanara Medtech INC. | $15.10 | 2024 | Celleraterx |
| Minerva Surgical, INC | $14.80 | 2024 | |
| Novo Nordisk INC | $14.61 | 2023 | |
| Avanos Medical | $14.16 | 2025 | On-Q Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bembry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.